Related Experiment Videos
[Prognosis factors associated with the progression of preeclampsia to eclampsia]
L A Villanueva Egan1, P Alanís López
1Hospital General Dr. Manuel Gea González, Secretaría de Salud.
Insights
Certain laboratory and clinical findings can predict preeclampsia progression to eclampsia. Elevated glucose, creatinine, AST, ALT, and LDH levels, along with nausea and vomiting, indicate increased risk.
Area of Science:
- Obstetrics and Gynecology
- Clinical Chemistry
Background:
- Preeclampsia is a serious pregnancy complication.
- Progression to eclampsia poses significant risks.
Purpose of the Study:
- To identify laboratory and clinical predictors for preeclampsia progression to eclampsia.
- To aid clinicians in managing preeclampsia risk.
Main Methods:
- Retrospective analysis of laboratory and clinical data.
- Identification of significant risk factors for eclampsia development.
Main Results:
- Nausea and vomiting are associated with increased eclampsia risk.
- Specific laboratory thresholds (glucose > 105 mg/dL, creatinine > 1.0 mg/dL, AST > 35 IU/L, ALT > 40 IU/L, LDH > 450 IU/L) predict progression.
- These findings offer prognostic value.
Conclusions:
- Laboratory and clinical markers can effectively estimate the risk of preeclampsia advancing to eclampsia.
- This predictive information supports clinical decision-making and patient management.
Abstract:
This study was undertaken to determine the prognosis value of laboratory and clinical findings in the progression of preeclampsia to eclampsia. Nausea and vomiting and glucose level > 105 mg/dL, serum creatinine level > 1.0 mg/dL, aspartate aminotransferase level > 35 IU/L, alanine aminotransferase level > 40 IU/L and lactate deshiydrogenase level > 450 IU/L can be used to estimate the risk for the advancement to eclampsia. This information could be helpful to the clinician for management purposes.